Annexon Inc reports results for the quarter ended in January - Earnings Summary

Annexon

12/08/2024 16:03

* Annexon Inc  ANNX.OQ  reported a quarterly adjusted loss
of 23
cents​​ per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of -47
cents.  The mean expectation of eight analysts for the quarter
was for a loss of 23 cents per share. Wall Street expected
results to range from -32 cents to -19 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Annexon Inc's reported EPS for the quarter was a loss
of 23
cents​.
    * The company reported a quarterly loss of $29.61 million.
    * Annexon Inc shares had risen by 11.8% this quarter and
gained 20.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 27.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Annexon Inc is
$14.00 
This summary was machine generated from LSEG data August 12 at
03:03 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.23          -0.23          Met
 Mar. 31 2024      -0.34          -0.21          Beat
 Dec. 31 2023      -0.44          -0.36          Beat
 Sep. 30 2023      -0.50          -0.43          Beat